Mitsutoshi Nakada Selected Research

Alkylating Agents

1/2012	The strategy for enhancing temozolomide against malignant glioma.
2/2011	The correlation between promoter methylation status and the expression level of O6-methylguanine-DNA methyltransferase in recurrent glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsutoshi Nakada Research Topics

Disease

73	Neoplasms (Cancer) 01/2024 - 01/2003
55	Glioma (Gliomas) 07/2023 - 01/2003
49	Glioblastoma (Glioblastoma Multiforme) 07/2023 - 01/2003
12	Aneurysm (Aneurysms) 01/2024 - 01/2004
9	Brain Neoplasms (Brain Tumor) 01/2020 - 11/2005
7	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2003
7	Hydrocephalus (Hydrocephaly) 01/2022 - 05/2010
6	Intracranial Aneurysm (Cerebral Aneurysm) 01/2023 - 01/2004
5	Hemorrhage 10/2022 - 11/2016
5	Astrocytoma (Pilocytic Astrocytoma) 09/2012 - 10/2005
4	Inflammation (Inflammations) 01/2022 - 12/2009
4	Meningioma (Meningiomas) 01/2022 - 02/2009
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021 - 08/2015
4	Germinoma 01/2021 - 08/2015
4	Ependymoma 01/2021 - 01/2018
3	Lung Neoplasms (Lung Cancer) 01/2024 - 03/2015
3	Lymphoma (Lymphomas) 04/2023 - 07/2015
3	Headache (Headaches) 01/2022 - 03/2017
3	Pathologic Constriction (Stenosis) 01/2021 - 10/2018
3	Cysts 01/2019 - 02/2017
3	Intellectual Disability (Idiocy) 06/2018 - 10/2016
3	Medulloblastoma 01/2016 - 08/2009
2	Combined Pituitary Hormone Deficiency 01/2022 - 01/2018
2	Carcinoma (Carcinomatosis) 01/2022 - 03/2015
2	Disease Progression 12/2021 - 06/2021
2	Pituitary Neoplasms (Pituitary Adenoma) 10/2021 - 04/2016
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2021 - 01/2021
2	Brain Ischemia (Cerebral Ischemia) 05/2020 - 01/2018
2	Meningeal Carcinomatosis 01/2020 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2013
2	Necrosis 06/2018 - 01/2018
2	Thalassemia 06/2018 - 10/2016
2	Adenocarcinoma of Lung 12/2017 - 03/2015
2	False Aneurysm (Pseudoaneurysm) 11/2016 - 05/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2016 - 01/2013

Drug/Important Bio-Agent (IBA)

13	Messenger RNA (mRNA)IBA 01/2021 - 05/2003
12	Temozolomide (Temodar)FDA LinkGeneric 06/2023 - 04/2007
10	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2003
10	Small Interfering RNA (siRNA)IBA 01/2019 - 11/2004
8	Biomarkers (Surrogate Marker)IBA 04/2023 - 04/2007
8	Glycogen Synthase KinasesIBA 01/2020 - 02/2009
8	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 05/2003
7	Phosphotransferases (Kinase)IBA 01/2021 - 11/2011
6	MethyltransferasesIBA 11/2022 - 11/2010
5	LigandsIBA 01/2019 - 09/2006
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 07/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2013
4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 05/2010
4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020 - 05/2010
4	AcidsIBA 03/2019 - 05/2010
4	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 01/2003
4	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2016 - 12/2009
3	Glutamic Acid (Glutamate)FDA Link 01/2024 - 07/2014
3	Bevacizumab (Avastin)FDA Link 11/2022 - 01/2014
3	Transcription Factors (Transcription Factor)IBA 04/2022 - 02/2011
3	AntibodiesIBA 11/2021 - 02/2009
3	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 12/2019
3	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2018
3	osimertinibIBA 01/2020 - 01/2016
3	Erythropoietin FDA Link 01/2020 - 01/2013
3	Therapeutic UsesIBA 01/2020 - 02/2009
3	Glycogen Synthase (Synthase I)IBA 10/2016 - 10/2013
3	EphrinsIBA 12/2013 - 09/2006
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2011 - 12/2009
2	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 12/2017
2	Hormones (Hormone)IBA 01/2022 - 07/2016
2	NivolumabIBA 12/2021 - 01/2018
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 04/2007
2	Glial Fibrillary Acidic ProteinIBA 10/2020 - 02/2011
2	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 10/2020 - 12/2008
2	Proteoglycans (Proteoglycan)IBA 05/2020 - 09/2005
2	Receptor for Advanced Glycation End ProductsIBA 05/2020 - 11/2019
2	O-(6)-methylguanineIBA 01/2020 - 10/2013
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 07/2014
2	Discoidin Domain Receptor 1IBA 01/2020 - 01/2013
2	tyrosine receptor (receptor, tyrosine)IBA 01/2020 - 01/2013
2	alectinibIBA 01/2020 - 03/2015
2	Ephrin-B2 (Ephrin B2)IBA 01/2019 - 03/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2018 - 11/2004
2	isocitric acid (isocitrate)IBA 06/2018 - 10/2014
2	ProlactinIBA 02/2018 - 04/2016
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 10/2009
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2018 - 07/2011
2	CrizotinibIBA 12/2017 - 03/2015
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 08/2016 - 01/2016
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/2016 - 02/2009
2	GadoliniumIBA 07/2016 - 05/2012

Therapy/Procedure

35	Therapeutics 01/2023 - 04/2007
11	Radiotherapy 06/2023 - 11/2010
10	Craniotomy 01/2023 - 12/2009
10	Drug Therapy (Chemotherapy) 04/2022 - 04/2007
5	Stents 01/2022 - 11/2016
5	Lasers (Laser) 03/2010 - 05/2004
4	Chemoradiotherapy 07/2023 - 07/2013
3	Ventriculostomy 02/2021 - 07/2016
2	Ventriculoperitoneal Shunt 01/2022 - 08/2016
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2022 - 01/2018
2	Decompression 01/2019 - 01/2018
2	Operative Surgical Procedures 01/2018 - 01/2015
2	Surgical Instruments (Clip) 09/2017 - 01/2004